COMMUNIQUÉS West-GlobeNewswire

New LockeT Data Accepted in Leading Electrophysiology Journal
06/04/2026
FORT MILL, S.C., April 06, 2026 (GLOBE NEWSWIRE) -- Catheter Precision, Inc. (NYSE American: VTAK) (“VTAK” or the “Company”) today announced that the manuscript titled “Safety and Efficacy of LockeT Suture Retention [...]
Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
06/04/2026
FLORHAM PARK, N.J., April 06, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) [...]
Oncolytics Biotech® Announces Type C FDA Meeting to Discuss Single-arm Registrational Pathway for Pelareorep in Anal Cancer
06/04/2026
SAN DIEGO, April 06, 2026 (GLOBE NEWSWIRE) -- Oncolytics Biotech ® Inc. (Nasdaq: ONCY) (“Oncolytics” or the “Company”), a clinical-stage immunotherapy company developing pelareorep, an investigational, systemically [...]
Extendicare Announces Timing of 2026 First Quarter Results and Conference Call
06/04/2026
MARKHAM, Ontario, April 06, 2026 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE) announced today that it plans to release its financial results for the first quarter of 2026 after market [...]
Geron to Participate in the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
FOSTER CITY, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a commercial-stage biopharmaceutical company aiming to change lives by changing the course of blood cancer, today announced that [...]
Stablecoin Development Corporation Begins Trading on NYSE American Under Ticker “SDEV”
06/04/2026
Company Announces Completion of Corporate Name Change and Provides Updated SKY Holdings and Staking Metrics EMERYVILLE, Calif., April 06, 2026 (GLOBE NEWSWIRE) -- Stablecoin Development Corporation (NYSE American: SDEV [...]
Inspire Medical Systems, Inc. to Report First Quarter 2026 Financial Results on May 4, 2026
06/04/2026
MINNEAPOLIS, April 06, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the first quarter 2026 after the close of trading on Monday, May 4. Inspire’s [...]
Curanex Highlights Patient Case Study Supporting Potential of Phyto-N in Cancer Cachexia and Advanced Cancer Supportive Care
06/04/2026
Case involving senior dosimetrist at a premier cancer hospital in the Northeast suggests potential relevance of Phyto-N in one of oncology’s most serious and underserved supportive-care markets Jericho, New York, April [...]
Stereotaxis Announces FDA Clearance and Launch of Synchrony System
06/04/2026
ST. LOUIS, April 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it has received U.S. Food [...]
Avalyn Appoints Jon Congleton, Seasoned Biopharmaceutical Executive, to its Board of Directors
06/04/2026
BOSTON, April 06, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare [...]
Sienna Senior Living recognized by The Globe and Mail’s Women Lead Here Benchmark
06/04/2026
MARKHAM, Ontario, April 06, 2026 (GLOBE NEWSWIRE) -- Sienna Senior Living, one of Canada’s leading owners and operators of senior living communities, has been recognized for the sixth consecutive year in The Globe and [...]
Zhengye Biotechnology Holding Limited Announces Implementation of Dual-Class Share Structure
06/04/2026
Jilin, China, April 06, 2026 (GLOBE NEWSWIRE) -- Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) (the “Company” or “Zhengye”), a veterinary vaccine manufacturer that encompasses research, development, manufacturing [...]
Beacon Biosignals Upsizes Series B Financing to Over $97 Million
06/04/2026
BOSTON, April 06, 2026 (GLOBE NEWSWIRE) -- Beacon Biosignals today announced an extension to its Series B financing, bringing the funding round to $97 million and the company’s cumulative funding to over $132 million. [...]
Sharps Technology Reports 2025 Year-End Results and Highlights Continued Execution of Solana Treasury Strategy
06/04/2026
Over 2 Million SOL Held with Approximately 95% Staked at ~7% Gross Annualized Yield Total Assets of $269.1 Million, Up from $7.3 Million at Year-End 2024 Expanded Solana Ecosystem Partnerships Including Coinbase, Crypto [...]
Profusa Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform
06/04/2026
Company secures scalable multi-omics diagnostics platform and launches Mayo Clinic partnership adding to Lumee real-time biochemistry monitoring platform to advance pancreatic cancer applications BERKELEY, CA, April 06 [...]
BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer
06/04/2026
— Experienced R&D leader with a track record of advancing innovative therapies from early development to global approval — RESEARCH TRIANGLE PARK, N.C., April 06, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, [...]
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference
06/04/2026
Immunocore to present at the 25th Annual Needham Virtual Healthcare Conference (OXFORDSHIRE, England & RADNOR, Penn. & GAITHERSBURG, Md., US, 06 April 2026) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” [...]
NRx Pharmaceuticals (Nasdaq:NRXP) Announces FDA Labeling Alignment for NRx’s Preservative-Free Ketamine Application
06/04/2026
NRx has received a letter from the FDA Office of Generic Drugs indicating preliminary alignment on labeling for NRx’s preservative-free ketamine product. Labeling remains subject to final supervisory review. NRx [...]
Neumora Therapeutics to Participate in 25th Annual Needham Virtual Healthcare Conference
06/04/2026
WATERTOWN, Mass., April 06, 2026 (GLOBE NEWSWIRE) -- Neumora Therapeutics, Inc. (Nasdaq: NMRA), a clinical-stage biopharmaceutical company with a therapeutics pipeline consisting of programs that target novel mechanisms [...]

Pages